Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study

Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy

(2012) R.M. Szeimies et al.   BRITISH JOURNAL OF DERMATOLOGY

Results of an Investigator-Initiated Single-Blind Split-Face Comparison of Photodynamic Therapy and 5% Imiquimod Cream for the Treatment of Actinic Keratoses

(2012) Jason Hadley et al.   DERMATOLOGIC SURGERY

A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes

(2012) Carlos Serra-Guillén et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Nonmelanoma Skin Cancer Chemoprevention

(2011) Renata Prado et al.   DERMATOLOGIC SURGERY

A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate

(2010) C. Serra-Guillen et al.   BRITISH JOURNAL OF DERMATOLOGY

Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study

(2009) Z. Apalla et al.   BRITISH JOURNAL OF DERMATOLOGY

Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities

(2009) E Sotiriou et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Photodynamic Therapy With Methyl Aminolevulinate for Prevention of New Skin Lesions in Transplant Recipients: A Randomized Study

(2009) Ann-Marie Wennberg et al.   TRANSPLANTATION